Business Wire

Commission Must Change Course on Reusable Packaging Demands – EPPA

17.11.2022 07:00:00 EET | Business Wire | Press release

Share

As the EU prepares to set strict new targets on packaging waste, a mounting body of evidence shows that proposed targets on reusables are unscientific, unsustainable and unnecessary.

The European Paper Packaging Alliance (EPPA) has issued fresh calls for the European Commission to put the full product life cycle at the heart of its vision for a circular economy, and not to use the upcoming Packaging and Packaging Waste Regulation proposal to effectively outlaw packaging solutions that are more sustainable.

The latest evidence comes from a new life cycle analysis study, which shows that recyclable, paper-based packaging used in the food delivery and takeaway sector offers significant environmental advantages over reusable systems across 12 ‘impact categories’ including climate change, freshwater consumption and resource depletion.

The results show that switching to reusable alternatives would generate 48% more CO2-equivalent emissions, consume 39% more freshwater and demand 82% more mineral and resource extraction.

Analysis of the results shows that this is because transporting food and beverage containers back to restaurants after use, together with washing and drying them hygienically, consumes far more energy, water and resources.

This LCA study adds to a range of other evidence which shows that reusable container systems are not the panacea which some seem to believe.

Commenting on the findings, Eric Le Lay, President of the European Paper Packaging Alliance said:

This is more proof that reusable packaging is not always the best solution for the environment. It is imperative that proper life cycle analysis be reflected in the text of the EU’s Packaging and Packaging Waste Regulation proposal.

The leaked draft text of the regulation is disappointing. It sets unrealistic and discriminatory reuse targets for in-store dining and takeaway services. The European Commission should embrace the scientific evidence that single-use, paper-based containers are not only far more practical for food delivery services and their customers, improving hygiene and convenience, but simply perform better on key environmental metrics.”

Antonio D’Amato, Vice President of EPPA, also commented:

Protecting the planet is too important a priority to be left to ideology. The planet's health demands a rigorous scientific approach and substantial investment in new technology and innovation, which can only be generated by sustainable growth.

Europe and indeed the entire world face energy and water scarcity and food shortages, yet the Commission's current proposals would escalate carbon emissions and resource depletion, accelerate water stress and increase food waste. We should instead be working together on solutions that are truly sustainable for the environment, the economy and employment. We are convinced that the circular economy, in which we have all invested billions of euros over 30 years’ hard work and innovation, is the only way to provide sustainable solutions for the environment, economy and employment.

The study was commissioned by EPPA. The full study including its methodology description is available for download here.

About EPPA
The European Paper Packaging Alliance is a non-for-profit food and foodservice packaging association. The priorities of the Alliance are to find concrete solutions to increase recycling and to reduce carbon emissions of food and foodservice packaging without compromising food safety and human health protection. More information is available here.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Roxana Moldovan
+32 485955210

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

WHOOP Expands Commitment to Women's Health by Including One-Year Subscription of Natural Cycles° App in Membership4.8.2026 12:00:00 EEST | Press release

WHOOP, the human performance company, today announced an expansion of its women’s health offering through an integration with Natural Cycles° (NC°), the only FDA-cleared, hormone-free birth control app. WHOOP is offering a 12-month subscription to the NC° app to eligible new Natural Cycles users. Members with compatible WHOOP devices can now automatically share overnight skin temperature with the NC° app to enable personalized fertility insights and hormone-free birth control. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260804399367/en/ WHOOP Expands Commitment to Women's Health by Including One-Year Subscription of Natural Cycles° App in Membership The Natural Cycles app, a Class II medical device, uses biomarker data, including temperature and heart rate data, to identify fertile and non-fertile days, helping users prevent pregnancy without hormones while also providing fertility insights. Beyond birth control, the app

Alphatax Makes Two Acquisitions to Strengthen Transfer Pricing Capabilities4.8.2026 11:00:00 EEST | Press release

Alphatax, the global tax compliance software provider, has today announced the acquisitions of TP Accurate and Intra Pricing Solutions, expanding its transfer pricing capabilities and reinforcing its ambition to build the world's first tax operating system. The acquisitions strengthen Alphatax's transfer pricing portfolio with complementary capabilities across financial transactions and documentation. TP Accurate provides specialist software for intra-group financing arrangements, while Intra Pricing Solutions' flagship product, TPGenie, enables multinational organisations and advisors to produce transfer pricing documentation using intelligent automation and AI. Together, they expand Alphatax's ability to support the full transfer pricing lifecycle, helping customers manage compliance more efficiently while improving governance and reducing audit risk. They also represent another step towards Alphatax's long-term vision for the future of tax technology. By bringing these transfer pric

LabPMM® Launches Global KMT2A MRD Testing Service to Support Menin Inhibitor Development and Acute Leukemia Care4.8.2026 10:10:00 EEST | Press release

LabPMM®, an Invivoscribe® subsidiary, today announced the global availability of its new KMT2A measurable residual disease (MRD) testing service. The highly sensitive digital PCR service is available to healthcare providers, clinical researchers, and biopharmaceutical partners through LabPMM’s global laboratory network, with CAP/CLIA-accredited testing available in the U.S. The service addresses a growing need for accurate molecular monitoring in acute leukemias.1,2,3 KMT2A rearrangements (KMT2Ar) are oncogenic drivers in acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL).4 These rearrangements are present in about 80% of infant cases and 5-15% of childhood and adult leukemia cases.5 KMT2Ar leukemias are associated with chemotherapy resistance, high relapse rates, and poor clinical outcomes.5 The emergence of menin inhibitors is transforming the therapeutic landscape for patients with AML and ALL, particularly those with KMT2A-rearranged and NPM1-mutated disease.6 The

Mosaic Therapeutics appoints Dr Allison Jeynes as Chair of the Board4.8.2026 10:00:00 EEST | Press release

Mosaic Therapeutics, Ltd, (‘Mosaic’, or ‘the Company’) an oncology therapeutics company developing novel, targeted drug combinations across a range of haematological and solid cancers, today announced the appointment of Dr Allison Jeynes as Chair of the Board to support its next phase of growth and advancement towards clinical development. Allison succeeds Dr Edward Hodgkin, who remains a Non-Executive Director of the Board. Allison is a UK-trained oncologist and highly-experienced life sciences leader, and brings over three decades of drug development and executive experience to Mosaic Therapeutics. As CEO of Avillion, a clinical development company, for the last 13 years, she has led global teams to achieve a 100% success rate from Phase 3 development through to FDA approval for multiple programs spanning oncology, immunology and respiratory medicine. In addition, she raised funds of around $400M as founder and CEO. Across her career she has contributed to 20 drug approvals, engaging

TOHKnet and Adtran conduct Japan’s first 50G PON trial on a live network4.8.2026 10:00:00 EEST | Press release

Adtran today announced that TOHKnet has completed Japan’s first live network trial demonstrating the coexistence of 50G PON, XGS-PON and EPON on a single fiber. Conducted in Sendai using Adtran’s SDX 6400 Series OLT, the demo showed how the platform enables three generations of PON technology to operate together in a live service environment. The results highlight a realistic path for operators to introduce 50G PON capacity while maintaining continuity for existing services, maximizing the value of deployed fiber assets and reducing the complexity and disruption typically associated with network upgrades. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260803353435/en/ Adtran’s SDX 6400 Series is helping TOHKnet demonstrate how Japan’s operators can migrate to 50G PON without disrupting existing PON services. “As demand for digital services continues to grow, this trial is a key milestone for the future of fiber access in Jap

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye